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SUMMARY 
• Structural, biochemical, and pharmacological stud 
ies have provided numerous insights into the role of rodent 
submandibular glands in a variety of physic/pathological 
functions. In this review we briefly highlight past and present 
findings published by our group and others regarding the ro 
le of rodent submandibular glands and nerve growth factor in 
inflammatory events. Accordingly, the role of mouse salivary 
glands and nerve growth factor in neuroinflammatory re 
sponses, body temperature and parasitic infection are dis 
cussed, and potential future lines of studies aimed at elucidat 
ing their physiopathological roles are suggested. 
(Biomed Rev 1998; 9: 93-99) 
INTRODUCTION 
• The submandibular glands (SMG) of rodents are di 
vided in two different functional and anatomical parts, the aci- 
nar and ductal regions. The acinar region contains the secretory 
cells which produce and release their products in the saliva. The 
acinar cells are structurally connected to each other by ducts 
linked to the granulated convoluted tubules, and then to the 
striated excretory ducts which store the wide variety of biologi 
cally active polypeptides. 
• The submandibular gland: innervation and growth 
factors 
SMG are innervated by sympathetic, parasympathetic and 
peptidergic nerves, and each set of terminal fields contributes 
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to the secretory regulation (1-4). Sympathetic activation has 
been shown to induce high protein secretion, and 
parasympathetic activation lead to more liquid saliva production 
(2-4). The SMG of mice contain small intrinsic 
cholinergic/peptidergic ganglia whose function is not clearly 
known. Structurally, mouse SMG are formed by highly 
differentiated epithelial cells capable of secreting more than 25 
different biologically active polypeptides (2,5-8). They 
contribute, with significant overlapping, to several functional 
activities involved in the regulation of homeostasis and digestion 
(4,9). There is considerable evidence indicating that growth 
factors released by SMG can contribute to reestablishing 
normal tissue function by promoting cell growth and 
proliferation, and by regulating inflammatory cell processes (9). 
Among these proteins, nerve growth factor (NGF) is the first 
polypeptide identified in salivary glands owing to its property of 
promoting growth and differentiation of peripheral sympathetic 
and embryonic sensory neurons (10). In the last fewyears, a 
number of studies have provided evidence that NGF plays a 
functional role in forebrain chol inergic neurons, and is also 
involved in inflammatory events (11-14) inside and outside the 
nervous system. 
The secretion of molecules stored in the SMG cells is regulated by 
stimuli arising from adrenergic, cholinergic and peptidergic 
neurons (15,16). Postganglionic sympathetic axons originating 
in the superior cervical ganglion (SCO) are located in a 
typical adrenergic ground plexus closely surrounding the SMG 
acini, while the ducts seem to be completely devoid of adrenergic 
innervation (17-20). Structural and biochemical studies have 
shown that adrenergic stimulation results in a depletion of 
secretion granules containing growth factors, including NGF 
(17,21). Removal of SCG decreased catecholamine fluorescence 
and thyroxine hydroxylase immunoreactivity in SCG (22,23), 
suggesting that, through adrenergic innervation, SCG neurons 
receive trophic support from the glands. Both a- and (3-adrener- 
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gic agents trigger the release of growth factors produced and 
stored in the glands, although degranulation of cells is more 
strongly iduced by a- than by (3-adrenergic stimuli. Exogenous 
administration of cyclocytidine, a drug stimulating oc-adrenergic 
receptors, produced drastic depletion of NGF from the granular 
convoluted tubules and increased NGF level in the blood 
(24). Decentralization of the SCG by surgical lesion of the 
preganglionic innervation did not significantly affect the SCG 
neurons (16) and/or the amount of NGF stored in the gland 
(unpublished observations). Reduction of adrenergic 
innervation occurs with age, an effect most probably associated 
with a low availability of NGF in the SMG. Administration of 
the cholinergic drug pilocarpine to adult rodents induced 
exocyto-sis of secretion granules in granular convoluted tubule 
cells 
(25). Decentralization or superior cervical ganglionectomy did 
not significantly affect the amount of substance P (SP) present in 
the SMG, which implies that this neuropeptide is not regulated 
by preganglionic or postganglionic sympathetic neurons 
projecting to the SMG (16). This observation suggests that SP is 
not associated with the SMG sympathetic innervation, but is 
anatomically and functionally related to the chorda tympani 
nerve and possibly involved in the parasympathetic innervation 
of the gland. Accordingly, sectioning of the chorda tympani nerve 
results in a significant decrease in SP content of the salivary 
glands. 
The SMG also possess rather small intrinsic ganglia located 
between the lingual nerve, and the submandibular and sublin-
gual gland ducts (26,27). The role of these intrinsic neurons in 
the activity of the SMG is not fully known; they are supposed to 
contribute to the secretory activity of the gland. 
SALIVARY NGF AMD THE ENDOCRINE 
SYSTEM 
• Although displaying mainly exocrine activity, the 
SMG also possess an endocrine function. One of the first 
indications that these glands displayed endocrine activities 
was reported by Ogata (28) whereas other studies provided 
evidence that the SMG are able to secrete various proteins (21). 
They are released by the secretory ducts into the bloodstream, 
most probably through the fenestrated capillaries underlying 
the ducts (1). Several studies have shown that NGF is produced, 
stored and released by the granular convoluted tubules of the 
SMG, and that its NGF content is higher in male than in female 
mice (29). The synthesis of growth factors in SMG is hormonally 
regulated (30). Indeed, testosterone enhances the levels of 
growth factors, while removal of testis and thyroid gland de 
creases them (3 1). Moreover, other studies have revealed that 
removal of the pituitary gland in rats induces atrophy of the SMG 
and decreases some immunosuppressive capabilities (32), while 
SMG extirpation is quickly followed by atrophy of the thymus 
associated with depletion of the thymus-dependent lympho 
cytes in the spleen and lymph nodes (33). This effect seems to 
be independent of age and sex. 
An involvement of SMG in endocrine mechanisms is also 
suggested by behavioral studies. Aggressive behavior causes 
massive degranulation in SMG and release of biologically active 
compounds such as epidermal growth factor, renin, and NGF 
(34). As hypothesized some years ago by Levi-Montalcini (10), 
the mouse salivary NGF seems to be implicated in the regulation of 
offensive and defensive behaviors. In fact, the increase of 
blood NGF in fighting mice was found to be associated with the 
number of agonistic episodes, and is more pronounced in 
submissive mice than in dominant mice (34-36). Thus the 
circulating NGF level in submissive mice was increased two-
fold compared with dominant animals (3 5). This study also 
indicates a relationship between the circulatingNGF levels in 
aggressive mice and the number of fighting episodes, though this 
relationship is valid only for dominant attacking mice when plasma 
NGF is analysed in both dominant and submissive animals. 
The amount of NGF released into the circulation of mice 
without SMG decreased drastically suggesting that during 
aggressive behavior, the main source of circulatingNGF is the 
SMG (3 5). It was also observed that chronic aggressive 
behavior in mice, which induces a massive release of salivary 
NGF into the bloodstream, can lead to the production of NGF 
autoantibodies, thus causing a significant decrease in peripheral 
sympathetic innervation(37). 
Recent studies suggest that adrenergic innervation of SMG 
participates to some extent in the regulation of NGF release into 
the circulation. For example, fighting mice, immunosympath-
ectomized with NGF antibody since birth or chemically sympa-
thectomized with 6-hydroxydopamine, still release high levels of 
NGF into the c irculation (35). Adrenalectomy failed to blockNGF 
release in fighting mice, and injections of ACTH or crude extract of 
adrenal gland or hypophysis in isolated adult male mice did not 
result in NGF release into the bloodstream, suggesting that 
mediators released by these glands do not exert a primary role in 
submandibular NGF release (35,38). A correlation between 
NGF and endocrine functions is suggested by other findings, 
indicating that NGF is able to stimulate the pituitary-adrenocor-
tical axis releasing ACTH and glucocorticoids (39), and that 
adrenal gland hormones alter the synthesis of NGF (38,40). 
Furthermore, administration of NGF antibodies into rat fetuses, 
which inhibits the availability and activity of endogenous NGF, 
induced a significant loss in body growth and a marked neuroen-
docrine deficit in the offspring (41). Likewise, deleterious neuro-
endocrine effects of NGF have been found in rabbits and guinea 
pigs after maternal exposure toNGF antibodies (42). Moreover, 
reproductive organs store and release significant physiological 
amounts ofNGF, suggestingthatthis molecule is implicated in 
the functional activity of these tissues (43), while changes in 
NGF concentration were found during late pregnancy or delivery 
in both plasma and central nervous system (44,45). 
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NEUROINFLAMMATORY RESPONSES AMD 
NGF 
• The first evidence showing that NGF is associated 
with inflammation was reported by Levi-Montalcini who found 
that experimentally induced granulomas are characterized by 
altered levels of NGF (46). Subsequent studies demonstrated 
thatNGFpromotesproliferation and degranulationofmast cells, 
and it was found that a large number of inflammatory diseases 
is characterized by high local NGF levels (reviewed in 44,45). 
Salivary NGF enhances vascular permeability (47), promotes 
differentiation of granulocytes (48), and induces lymphocyte 
proliferation (49) and mast cell degranulation (50). The eviden 
ce that NGF promotes wound healing (51) further suggests that 
this molecule is involved in the modulation of different inflam 
matory responses (9). Though the tissues of the immune system 
are known to be innervated by the sympathetic nervous system 
(52), the mechanisms regulating the innervation of specific 
'tissues are at present not fully understood. Sympathetic nerve 
tenninals in immune tissues are found to sun'ound blood vessels 
and T cells areas within lymphoid organs, such as spleen, lymph 
nodes, and gut-associated lymphoid tissues (53). NGF is also 
involved in peripheral inflammatory responses (54), playing a 
crucial role in neuropathologies associated with sensory defi 
cits (55). Our laboratory studies indicate that NGF increases in 
several neuroinflammatory diseases (44). A high NGF level has 
been found in patients with rheumatoid arthritis (56), systemic 
sclerodemia(57), lupuserythematosus(58,59), Kawasaki dis 
ease (59a), multiple sclerosis (60) as well as in rodents affected 
by experimental allergic encephalomyelitis (61,62), an animal in 
flammatory disorder model considered to closely resemble the 
human diseases multiple sclerosis and rheumatoid arthritis. We 
have also shown that pretreatment with NGF antibody reduces 
or prevents the development of arthritis induced by carrag- 
eenan, suggesting a functional role of NGF in this type of per- 
pheral inflammation (63). Similarresults were obtained with arth 
ritic transgenic mice expressing high levels of TNF-cc in knee 
joints (64). 
It has been reported that certain neuroinflammatory diseases 
may also be characterized by low levels or absence of circulating 
NGF and, surprisingly, by a concomitant increase in NGF 
antibodies (64a). This may due to the generation of autoantibod-ies 
against NGF by chronic exposure to supranormal NGF amounts in 
the bloodstream. In fact, evidence supporting this hypothesis 
was obtained in our laboratory in chronically stressed mice 
(37). Furthermore, it was recently reported that the NGF level is 
decreased, whereas the p75 NGF receptor is overexpre-ssed in 
human atherosclerotic coronary arteries (65). 
SIALECTOMY, NGF 
ANDTHERMOREGULATION 
• It was recently demonstrated that salivary NGF is 
implicated in the regulation of the temperature set point in adult 
mice (66). Thus, circulatingNGF levels are low in hypothennic 
and high in hyperthennic mice, whereas injection of purified 
NGF into the tail vein of normal mice induces an increase in body 
temperature lasting about 6 hours (66). The observation that 
body temperature returned to normal values after 6 hours, while 
the concentration of circulating NGF was still high about 48 
hours suggests that NGF may be involved in the early response, 
most probably via the activation of cells of the neuroendocrine 
axis (39,67). The hypothesis that NGF plays a role in temperature 
response is also suggested by other observations. For example, 
supranormal levels of NGF occur in pathophysiological 
conditions associated with changes in body temperature 
(reviewed in 68), such as inflammatory responses (69-71). The 
mechanism leading to NGF increase as a result of body 
temperature elevation is at present not known. Since NGF 
synthesis is known to be regulated by cytokines (69.72), the 
possibility exists that the high levels of NGF are due to the 
supranormal expression of these molecules during inflammation. 
Other studies have shown that SMG are involved in 
inflammatory responses (9), and that salivary NGF acts on 
cells of the endocrine and immune systems (52,73). Because the 
hypothala-mus expresses NGF and NGF receptors (13,35,74-76), 
another possibility is that hypothalamic NGF-positive neurons 
might themselves be involved in these events. This 
hypothesis is supported by evidence demonstrating that a 
dramatic increase in the expression of NGF occurs in the 
hypothalamus in response to infection and high body 
temperature (77). Interestingly, brain ischemia, which alters body 
temperature (78), is also characterized by an increase in NGF and 
mRNANGF, while in-tracerebral administration of NGF antibodies 
during fetal life induces in the offspring physical and behavioral 
characteristics associated with deficits in thermoregulation (41). 
Since NGF acts on a variety of cells (10,14,73), the release of 
NGF during variation of body temperature may well serve to 
activate NGF responsive cells associated with homeostatic 
regulation. 
SALIVARY GLANDS AMD PARASITIC 
INFECTION 
• To gain further information about the role of salivary 
NGF in inflammatory responses, we recently earned out studies 
on mice infected with the trematode Schistosoma mansoni. 
Schistosomiasis is a disease that affects more than two million 
people in countries of South America, Africa, and Arabia. A key 
pathogenetic event in this parasitic infection is the formation of 
granulomas around schistosome eggs trapped in the intestine 
and liver (79). Immunological. pharmacological, biochemical, 
and molecular studies have shown that cytokines secreted by 
macrophages, eosinophils, mast cells, and Th-1 and Th-2 lym 
phocytes play a crucial role in the formation of these granulomas 
(79,80). We have shown that NGF occupies a key position in the 
regulation of parasitic inflammation. Our studies demonstrated 
that in addition to immunological changes, Schistosoma manso- 
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ni infection induces an increase in liver and brain NGF, the 
increase of NGF followed by an accumulation of mast cells around 
the granulomas (77,81). We also found that the exogenous 
administration of NGF antibodies significantly reduced the 
presence of these cells and restored the altered thermoregulation 
induced by schistosomiasis (66). Our findings also indicated a 
hyperalgesic effect in infected compared with uninfected animals 
on the hot-plate (82), whereas this nociceptive effect was not 
observed in infected-sialectomized animals (83). Since NGF 
administration induces hyperalgesia(54,55), and NGF is known to 
increase during chronic infection in the paws and in the brain (81), 
it has been hypothesized that the altered nociceptive expression is 
related to an increased level of paw NGF in infected mice, while 
the absence ofhyperalgesia in infected-sialectomized mice is most 
probably due to a reduced presence of NGF following SMG 
removal. This latter hypothesis is consistent with the observations 
that the removal of SMG in mice decreases the plasmaNGF 
concentration (84), and that infected sialectomized ' mice show 
similar NGF levels in the plasma compared with uninfected 
controls (66). However, whetherthese latter effects are directly 
induced by NGF or mediated through the effect of NGF on 
inflammatory cells and/or cytokines remains to be verified. 
CONCLUSION 
• Since its discovery, the presence of large quantities of 
NGF and other growth factors secreted by the mouse SMG has 
aroused considerable interest in their pathophysiological func 
tion. Although salivary glands products are found in the blood 
stream under conditions of stress, a still unresolved question is 
whether under normal conditions SMG have to be considered 
exclusively an exocrine gland or a gland displaying also endo 
crine activity. As peripheral blood and endocrine cells are recep 
tive to NGF action, it is highly possible that in appropriate phy 
siological states, SMG-derived growth factors can reach the 
bloodstream regulating the activity of these cells. This hypoth 
esis is supported by findings reported by our group and others 
showing that mouse SMG release NGF and other growth fac 
tors during aggressive encounters. Because NGF has been imp 
licated in autoimmune inflammatory disorders, a potentially 
important line of research that might be pursued involves the 
role of SMG and NGF in Sjugren's syndrome (SS), an autoim 
mune inflammatory disease associated with systemic lupus 
erythematosus (85), characterized by periductal infiltration of 
mononuclear cells leading to severe immunological, neurologi 
cal, and functional deficits of the SMG (86). Significantly, a 
recent study indicated that the constitutive level of epidermal 
growth factor, a peptide also produced in the SMG (4), under 
went significant changes in SS (87). The availability of a mouse 
strain that spontaneously develops a systemic lupus erythema- 
tosus-like syndrome renders the possibility of addressing the 
se questions more feasible. Other areas of research involve 
studying the hypothesis that SMG and/or growth factors se- 
creted by these glands are involved in tumor growth (88), 
muscular dystrophy (89,90), pulmonary inflammation (91,92), 
and aging(93). 
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